Person

Jason Pitofsky

SVP Controller, Regeneron Pharmaceuticals

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$6.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 4, 2026REGNSale439$939.57$412K
Nov 4, 2026REGNSale575$940.46$541K
Nov 4, 2026REGNSale982$941.58$925K
Nov 4, 2026REGNSale1,215$942.31$1.1M
Nov 4, 2026REGNSale529$943.53$499K
Nov 4, 2026REGNSale108$944.22$102K
Nov 4, 2026REGNSale35$945.61$33K
Nov 4, 2026REGNSale179$950.76$170K
Feb 9, 2026REGNSale521$776.43$405K
Feb 9, 2026REGNSale53$785.72$42K
Feb 9, 2026REGNSale1$784.66$785
Feb 9, 2026REGNSale144$783.23$113K
Feb 9, 2026REGNSale37$782.67$29K
Feb 9, 2026REGNSale26$781.37$20K
Feb 9, 2026REGNSale75$780.06$59K
Feb 9, 2026REGNSale205$779.56$160K
Feb 9, 2026REGNSale563$778.35$438K
Feb 9, 2026REGNSale20$775.95$16K
Feb 9, 2026REGNSale391$777.51$304K
Nov 7, 2025REGNSale431$651.43$281K
Aug 7, 2024REGNSale487$1,070.00$521K

SEC reporting-owner ID (CIK) 2009236 · all filings on EDGAR